Inhibrx Biosciences Inc. ( INBX) - Key Metrics
INBX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$2.34 | -$1.91 | -$1.91 |
| 2026Q1 | $0 | -$2.15 | -$2.44 | -$2.44 |
| 2025Q4 | $0 | -$2.12 | -$1.94 | -$1.94 |
| 2025Q3 | $0 | -$2.28 | -$2.19 | -$2.19 |
| 2025Q2 | $0.08 | -$1.85 | -$1.94 | -$1.94 |
INBX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -10.12 |
| 2026Q1 | 0% | -7.82 |
| 2025Q4 | 0% | -9.36 |
| 2025Q3 | 0% | -3.69 |
| 2025Q2 | 0% | -1.93 |
INBX
Price: $88.37
52 week price:
Earnings Per Share: -8.12 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 275430
Market Capitalization: 1.3 billion